Page last updated: 2024-08-22

coralyne and ER-Negative PR-Negative HER2-Negative Breast Cancer

coralyne has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Badana, AK; Kumari, S; Malla, RR; Mohan, MG; Shailender, G	1

Other Studies

1 other study(ies) available for coralyne and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line. Journal of cellular biochemistry, 2019, Volume: 120, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Berberine Alkaloids; Caspase 3; Cell Line, Tumor; DNA Damage; DNA Fragmentation; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Paclitaxel; Triple Negative Breast Neoplasms	2019

Article

Year

Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line.

Journal of cellular biochemistry, 2019, Volume: 120, Issue:10

Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Berberine Alkaloids; Caspase 3; Cell Line, Tumor; DNA Damage; DNA Fragmentation; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Paclitaxel; Triple Negative Breast Neoplasms

2019